(Q40449518)

20 September 2017

1 reference

title

Antineoplastic agents. Drug interactions of clinical significance. (English)

1 reference

20 September 2017

E van Meerten

1

1 reference

20 September 2017

J Verweij

series ordinal

2

1 reference

20 September 2017

J H Schellens

series ordinal

3

1 reference

20 September 2017

1 March 1995

1 reference

20 September 2017

1 reference

20 September 2017

12

1 reference

20 September 2017

168-182

1 reference

20 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/00002018-199512030-00003

20 September 2017

0 references

cites work

The influence of cimetidine on the pharmacokinetics of 5-fluorouracil

1 reference

12 December 2020

Combination 6-mercaptopurine-adriamycin in refractory adult acute leukemia

1 reference

12 December 2020

Decreased phenytoin levels in patients receiving chemotherapy

1 reference

12 December 2020

Pharmacokinetic rationale for the interaction of 5-fluorouracil and misonidazole in humans

1 reference

12 December 2020

Toxic hepatitis due to combination therapy with methotrexate and etretinate in psoriasis

1 reference

12 December 2020

High-dose Methotrexate Therapy-An Area of Uncertainty*

1 reference

12 December 2020

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

1 reference

12 December 2020

Increased teniposide clearance with concomitant anticonvulsant therapy

1 reference

12 December 2020

Reduction of toxicity of interleukin-2 and lymphokine-activated killer cells in humans by the administration of corticosteroids

1 reference

12 December 2020

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

12 December 2020

Renal insufficiency in patients treated with high dose methotrexate

1 reference

12 December 2020

Increased incidence of hypersensitivity to iodine-containing radiographic contrast media after interleukin-2 administration

1 reference

12 December 2020

Phase II trial of a combination of doxorubicin and mitoxantrone in metastatic breast cancer.

1 reference

12 December 2020

Allopurinol modulation of fluorouracil toxicity

1 reference

12 December 2020

Cisplatin-induced changes in bleomycin elimination

1 reference

12 December 2020

Decreased serum concentrations of tamoxifen and its metabolites induced by aminoglutethimide

1 reference

12 December 2020

Ifosfamide/mesa and encephalopathy

1 reference

12 December 2020

Qualitative defects of pseudocholinesterase activity

1 reference

12 December 2020

An interaction between cytostatic and anticonvulsant drugs

1 reference

12 December 2020

Dechloroethylation of ifosfamide and neurotoxicity

1 reference

12 December 2020

Sequences of taxol and cisplatin: a phase I and pharmacologic study

1 reference

12 December 2020

Intravenous infusions of ifosfamide/mesna and perturbation of warfarin anticoagulant control

1 reference

12 December 2020

Evaluation of aminoglycoside disposition in patients previously treated with cisplatin

1 reference

12 December 2020

Adriamycin and mitomycin C: possible synergistic cardiotoxicity

1 reference

12 December 2020

Interaction of etretinate with methotrexate pharmacokinetics in psoriatic patients

1 reference

12 December 2020

Irreversible encephalopathy with ifosfamide/mesna

1 reference

12 December 2020

Potentiation of ifosfamide neurotoxicity, hematotoxicity, and tubular nephrotoxicity by prior cis-diamminedichloroplatinum(II) therapy

1 reference

12 December 2020

Safe use of succinylcholine during repeated anesthetics in a patient treated with cyclophosphamide.

1 reference

12 December 2020

The effect of methotrexate on the bioavailability of oral 6-mercaptopurine

1 reference

12 December 2020

Influence of interferon alfa-2b with or without folinic acid on pharmacokinetics of fluorouracil

1 reference

12 December 2020

The pharmacology of orally administered chemotherapy. A reappraisal

1 reference

12 December 2020

Alteration of etoposide pharmacokinetics and pharmacodynamics by cyclosporine in a phase I trial to modulate multidrug resistance

1 reference

12 December 2020

Clinico-pathologic correlation of liver damage in patients treated with 6-mercaptopurine and Adriamycin

1 reference

12 December 2020

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

12 December 2020

Possible interactions between warfarin and 5-fluorouracil

1 reference

12 December 2020

Pharmacogenetics of acute azathioprine toxicity: relationship to thiopurine methyltransferase genetic polymorphism

1 reference

12 December 2020

Adriamycin cardiomyopathy--risk factors

1 reference

12 December 2020

Neutropenia and thrombocytopenia in renal allograft recipients treated with trimethoprim-sulfamethoxazole

1 reference

12 December 2020

Clinical Pharmacokinetics of Methotrexate1

1 reference

12 December 2020

Rapid development of enhanced clearance after high-dose cyclophosphamide

1 reference

12 December 2020

Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients

1 reference

12 December 2020

Biochemical modulation of fluorouracil with leucovorin and interferon: preclinical and clinical investigations

1 reference

12 December 2020

The effects of cyclosporine on the pharmacokinetics of doxorubicin in patients with small cell lung cancer.

1 reference

12 December 2020

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

1 reference

12 December 2020

Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism

1 reference

12 December 2020

Phenobarbital effects on cyclophosphamide pharmacokinetics in man

1 reference

12 December 2020

Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection

1 reference

12 December 2020

Effect of aminoglutethimide on antipyrine, theophylline, and digitoxin disposition in breast cancer

1 reference

12 December 2020

High-dose ifosfamide with mesna uroprotection: a phase I study

1 reference

12 December 2020

Delayed reactions to contrast media after interleukin-2 immunotherapy

1 reference

12 December 2020

The pharmacokinetics of high dose cyclophosphamide and high dose etoposide

1 reference

12 December 2020

Atypical contrast reactions associated with systemic interleukin-2 therapy

1 reference

12 December 2020

Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation

1 reference

12 December 2020

Effect of oral prophylactic broad spectrum nonabsorbable antibiotics on the gastrointestinal absorption of nutrients and methotrexate in small cell bronchogenic carcinoma patients

1 reference

12 December 2020

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

1 reference

12 December 2020

Modulation of 5-fluorouracil toxicity by allopurinol in man

1 reference

12 December 2020

Effect of aspirin and sulindac on methotrexate clearance

1 reference

12 December 2020

Human pharmacogenetics of methyl conjugation

1 reference

12 December 2020

Cyclophosphamide, Cholinesterase and Anaesthesia*

1 reference

12 December 2020

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

12 December 2020

Interaction of allopurinol with 6-mercaptopurine and azathioprine

1 reference

12 December 2020

1 reference

12 December 2020

Clinical pharmacokinetics of allopurinol

1 reference

12 December 2020

The Biotransformation of Cyclophosphamide in Man: Influence of Prednisone

1 reference

12 December 2020

Drug interactions with methotrexate.

1 reference

12 December 2020

Life threatening interaction between tamoxifen and warfarin.

1 reference

12 December 2020

Pharmacokinetic interaction between high-dose methotrexate and amoxycillin

1 reference

12 December 2020

The effect of verapamil on the pharmacokinetics of adriamycin.

1 reference

12 December 2020

Megaloblastic pancytopenia in a patient receiving concurrent methotrexate and trimethoprim-sulfamethoxazole treatment

1 reference

12 December 2020

Inhibition of theophylline metabolism by interferon

1 reference

12 December 2020

Influence of Platinum-Induced Renal Toxicity on Bleomycin-Induced Pulmonary Toxicity in Patients with Disseminated Testicular Carcinoma

1 reference

12 December 2020

Fatal pulmonary bleomycin toxicity in cisplatin-induced acute renal failure

1 reference

12 December 2020

Clinical pharmacology of cyclophosphamide

1 reference

12 December 2020

Alteration of dacarbazine pharmacokinetics after interleukin-2 administration in melanoma patients

1 reference

12 December 2020

1 reference

12 December 2020

Interaction of cyclosporin A with antineoplastic agents

1 reference

12 December 2020

Sequence-dependent cytotoxic effects due to combinations of cisplatin and the antimicrotubule agents taxol and vincristine

1 reference

12 December 2020

Ifosfamide neurotoxicity is related to previous cisplatin treatment for pediatric solid tumors

1 reference

12 December 2020

Oral bioavailability of mesna tablets

1 reference

12 December 2020

Prolongation and enhancement of serum methotrexate concentrations by probenecid

1 reference

12 December 2020

Delayed cardiac toxicity from anthracycline therapy

1 reference

12 December 2020

Effects of sodium warfarin and other carcinostatic agents on malignant cells: a study of drug synergy.

1 reference

12 December 2020

Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding

1 reference

12 December 2020

Effects of alpha-interferon on theophylline pharmacokinetics and metabolism

1 reference

12 December 2020

Oral melphalan pharmacokinetics: influence of interferon-induced fever

1 reference

12 December 2020

Adverse reactions to intravenous contrast media in patients treated with interleukin-2.

1 reference

12 December 2020

The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer

1 reference

12 December 2020

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma

1 reference

12 December 2020

Clinical trials of modulation of multidrug resistance. Pharmacokinetic and pharmacodynamic considerations

1 reference

12 December 2020

Preclinical and clinical aspects of biomodulation of 5-fluorouracil

1 reference

12 December 2020

Interaction of cimetidine with oral melphalan. A pharmacokinetic study

1 reference

12 December 2020

Prolonged apnea following succinylcholine in cancer patients receiving AB-132

1 reference

12 December 2020

Enhanced bleomycin toxicity during acute renal failure

1 reference

12 December 2020

Interaction between trimethoprim-sulfamethoxazole and methotrexate in children with leukemia

1 reference

12 December 2020

A controlled trial of the effect of 4-hydroxypyrazolopyrimidine (allopurinol) on the toxicity of a single bolus dose of 5-fluorouracil

1 reference

12 December 2020

Cardiomyopathy after widely separated courses of adriamycin exacerbated by actinomycin-D and mithramycin

1 reference

12 December 2020

Drug monitoring of etoposide (VP16-213). Correlation of pharmacokinetic parameters to clinical and biochemical data from patients receiving etoposide

1 reference

12 December 2020

A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome

1 reference

12 December 2020

Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol

1 reference

12 December 2020

Contrast medium "recalls" interleukin-2 toxicity

1 reference

12 December 2020

HEPATOTOXICITY OF MERCAPTOPURINE

1 reference

12 December 2020

Clinical pharmacokinetics of doxorubicin

1 reference

12 December 2020

Neoadjuvant therapy for advanced head and neck cancer with allopurinol-modulated high dose 5-fluorouracil and cisplatin. A phase I-II study

1 reference

12 December 2020

Inhibition of interleukin-2-induced tumor necrosis factor release by dexamethasone: prevention of an acquired neutrophil chemotaxis defect and differential suppression of interleukin-2-associated side effects.

1 reference

12 December 2020

Clinical and pharmacokinetic effects of combined warfarin and 5-flourouracil in advanced colon cancer

1 reference

12 December 2020

The effect of prior cisplatin therapy on the pharmacokinetics of high-dose methotrexate

1 reference

12 December 2020

Tamoxifen-warfarin interaction: the Aberdeen hospitals drug file

1 reference

12 December 2020

Life threatening interaction between tamoxifen and warfarin

1 reference

12 December 2020

Phase I pharmacokinetic study of cyclosporin A combined with doxorubicin

1 reference

12 December 2020

Disturbance of 6-mercaptopurine metabolism by cotrimoxazole in childhood lymphoblastic leukaemia

1 reference

12 December 2020

Aminoglutethimide and warfarin. A new important drug interaction

1 reference

12 December 2020

Life-threatening acute hyponatraemia induced by low dose cyclophosphamide and indomethacin

1 reference

12 December 2020

A call for caution in the use of aminoglutethimide: negative interactions with dexamethasone and beta blocker treatment.

1 reference

12 December 2020

10.2165/00002018-199512030-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference